Mastodawn

A Phase 1b clinical trial of Eli Lilly’s gene therapy VERVE-102 has shown up to 62% reduction in LDL cholesterol with a single dose, raising hopes for long-term treatment of hypercholesterolaemia and heart disease risk. https://english.mathrubhumi.com/lifestyle/health/one-time-gene-therapy-ldl-cholesterol-lowering-sh8q28ss?utm_source=dlvr.it&utm_medium=mastodon #GeneTherapy #BadCholesterol #Biotechnology #ClinicalTrial

Tadonic the Flautulent 11h ago

Eli Lilly is preparing a phase 2 trial for VERVE-102, a one-time gene editor acquired from Verve Therapeutics. The highest dose cut LDL cholesterol by 62% in patients, a reduction sustained for up to 18 months across 35 participants.

The treatment permanently switches off PCSK9, a cholesterol-producing gene, using base editing that flips a single DNA letter without breaking the double helix.

#news #health #medicine #cholesterol #GeneTherapy #GeneEditing

Global Feed 22h ago

تحليل SWOT جديد لـ CRISPR Therapeutics يكشف عن ضغوط تنافسية قوية في قطاع العلاج الجيني. 🌟
• **النقاط الرئيسية**: الشركة تواجه تحديات من المنافسين المحتملين، لكن فرص كبيرة في تطوير العلاجات الجينية المبتكرة.
• **الخبرة المفيدة**: استثمر في البنية التحتية التكنولوجية وتابع تطورات القطاع.

#CRISPR #GeneTherapy #Investing #Biotech #Tech

🔗 https://news.google.com/rss/articles/CBMickFVX3lxTE1QdWNwTFlvMWl6RVFCRk9yZVFNRUk4a0sxNjhjdDY2c3NWR01ta1o0S3JwYjllSm5wd3Z0SVBDaERaTHRSLXZRYWdHeGtoRUpkUG5CdWlpci1hY2pocmVHaVV1TW8xaXZFYkplN2p1UkdiQQ?oc=5

Before you continue

Eric Darnley Small 1d ago

One infusion. One time. Possibly forever. A breakthrough gene-editing treatment just slashed LDL "bad" cholesterol by up to 62% — and the results are holding 18 months later. Published in the New England Journal of Medicine, the small study of 35 patients could reshape how we fight heart disease, which kills 800,000 Americans annually. No daily pills. No repeat treatments. Just one shot. Experts call it potentially "game-changing." Larger trials are next — but the early signs are extraordinary. The future of heart health may have just arrived. #HeartDisease #GeneTherapy #MedicalBreakthrough #Cholesterol #Health #Science #Medicine #NEJM #Innovation #Healthcare https://www.nytimes.com/2026/05/25/health/cholesterol-ldl-gene-therapy.html?unlocked_article_code=1.lVA.l-ru.p7FYphe9x4Tx&smid=nytcore-android-share

One-and-Done Heart Disease Prevention? Scientists Show It May Be Possible.

A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point to something “curative,” one expert said.

The New York Times

Show thread

Biohacking Pathway May 19

#GeneMutations #Allergies #GutHealth #FoodSensitivities #Genetics #Health #Science #Wellness #GeneTherapy #wellbeingwarrior #wellnes #wellbeingcoach #wellnessblog #wellnesswins #wellnessmatters #holisticwellbeing #GutMotility https://mastodon.social/@biohackingpathway/116598851625639268

Nonya Bidniss May 16

AAV gene therapy vector induced a child's brain cancer 4 years after it cured his genetic disease. Risk of such cancers still considered low; it was likely caused by several factors present at once. #GeneTherapy https://www.science.org/content/article/boy-s-brain-tumor-tied-gene-therapy

MedBridgeNZ May 15

Seeking advanced gene therapies in China offers new possibilities, but the logistics can be overwhelming. MedBridgeNZ handles the complex visas, language barriers, and hospital coordination so you can simply focus on your loved ones.

Link in comments for a free case review!

Further Reading: https://zurl.co/nGG7g

#MedicalTourism #GeneTherapy #HealthcareLogistics #MedBridgeNZ

Disclaimer: MedBridgeNZ is a medical logistics concierge, not a clinical provider. Always consult your physician.

MedBridgeNZ May 14

Facing $2M+ price tags for SMA or Thalassemia treatments?

Top-tier hospitals are making Gene Therapy in China a viable clinical pathway for international families.

As a dedicated medical concierge provider, MedBridgeNZ handles the complex S1 visas, clinical translations, and specialist access so you can focus on care.

Read our full guide to Medical Tourism China & cross-border care here: https://zurl.co/Jq1qW

#MedicalTourismChina #GeneTherapy #SMA #HealthcareConcierge #MedBridgeNZ

Gene Therapy in China: Costs, Top Hospitals & Access

Home > Blog > Advanced Therapies & TechnologyKey Takeaways • High-Volume Clinical Experience: Top-tier hospitals in China, such as the Children's Hospital of Fudan University, process a significant volume of rare disease cases, providing multidisciplinary teams (MDTs) with extensive data and practical expertise. • Advanced Base-Editing Technology: Chinese researchers are utilizing transformer Base Editor (tBE) technology in clinical trials, which aims to modify specific bases without causing D

Medbridge Nz

Scientific Frontline May 14

Adenine base editing, a highly targeted form of genetic medicine, has been successfully deployed in a preclinical mouse model to correct the specific DNA mutation (SCN1A) responsible for Dravet syndrome, a severe and often fatal form of childhood epilepsy.
#MolecularGenetics #Neurobiology #GeneTherapy #PrecisionMedicine #sflorg
https://www.sflorg.com/2026/05/gen05142601.html

Precision DNA editing targets root cause of severe childhood epilepsy in preclinical study

Learn how precision adenine base editing targets the SCN1A mutation to correct the root cause of Dravet syndrome, a severe childhood epilepsy.

Ken Everett (Ken's Blogspot)May 12

#GeneSimmons Announces Gene Simmons Announces Legends of Rock Expo with Members -
https://kensbookinfo.blogspot.com/p/media.html#7

#GeneTherapy Gene Therapy May Finally Reach The Right Cells -
https://kensbookinfo.blogspot.com/p/business.html#43

#JamesComey #OnToddBlanche James Comey Levels Sick Burn On Todd Blanche -
https://kensbookinfo.blogspot.com/p/uk.html#4

#LizaMinnelli Buyers of Liza Minnelli memoir claim it was not signed -
https://kensbookinfo.blogspot.com/p/uk.html#9

View all news from Ireland https://kensbookinfo.blogspot.com/2026/03/latest-news-from-ireland.html

Media

The latest news and headlines, featuring real time updates for countries, cities, states, politics, economy, sports, food, culture via Ken's Blogspot